North America Human Liver Models Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Human Liver Models Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Human Liver Models Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Human Liver Models Market Regional Analysis

6.2 North America Human Liver Models Market Revenue 2019-2028 (US$ Thousand)

6.3 North America Human Liver Models Market Forecast Analysis

7. North America Human Liver Models Market Analysis – by Type

7.1 Liver Organoids

7.1.1 Overview
7.1.2 Liver Organoids: North America Human Liver Models Market – Revenue and Forecast, 2019-2028 (US$ Thousand)

7.2 Liver-on-a-chip

7.2.1 Overview
7.2.2 Liver-on-a-chip: North America Human Liver Models Market – Revenue and Forecast, 2019-2028 (US$ Thousand)

7.3 2D Models

7.3.1 Overview
7.3.2 2D Models: North America Human Liver Models Market – Revenue and Forecast, 2019-2028 (US$ Thousand)

7.4 3D Bioprinting

7.4.1 Overview
7.4.2 3D Bioprinting: North America Human Liver Models Market – Revenue and Forecast, 2019-2028 (US$ Thousand)

8. North America Human Liver Models Market Analysis – by Application

8.1 Drug Discovery

8.1.1 Overview
8.1.2 Drug Discovery: North America Human Liver Models Market – Revenue and Forecast, 2019-2028 (US$ Thousand)

8.2 Educational

8.2.1 Overview
8.2.2 Educational: North America Human Liver Models Market – Revenue and Forecast, 2019-2028 (US$ Thousand)

9. North America Human Liver Models Market Analysis – by End User

9.1 Pharmaceutical and Biotechnology Companies

9.1.1 Overview
9.1.2 Pharmaceutical and Biotechnology Companies: North America Human Liver Models Market – Revenue and Forecast, 2019-2028 (US$ Thousand)

9.2 Research Institutes

9.2.1 Overview
9.2.2 Research Institutes: North America Human Liver Models Market – Revenue and Forecast, 2019-2028 (US$ Thousand)

10. North America Human Liver Models Market – North America Analysis

10.1 Overview

10.2 North America

10.2.1 North America Human Liver Models Market Breakdown, by Key Country, 2022 and 2028 (%)
10.2.1.1 North America Human Liver Models Market – Revenue and Forecast Analysis – by Country
10.2.1.1 US: North America Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousand)

10.2.1.1.1 US: North America Human Liver Models Market Breakdown, by Type
10.2.1.1.2 US: North America Human Liver Models Market Breakdown, by Application
10.2.1.1.3 US: North America Human Liver Models Market Breakdown, by End User

10.2.1.2 Canada: North America Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousand)

10.2.1.2.1 Canada: North America Human Liver Models Market Breakdown, by Type
10.2.1.2.2 Canada: North America Human Liver Models Market Breakdown, by Application
10.2.1.2.3 Canada: North America Human Liver Models Market Breakdown, by End User

10.2.1.3 Mexico : North America Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousand)

10.2.1.3.1 Mexico : North America Human Liver Models Market Breakdown, by Type
10.2.1.3.2 Mexico : North America Human Liver Models Market Breakdown, by Application
10.2.1.3.3 Mexico : North America Human Liver Models Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 BioIVT

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 CELLINK

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Emulate, Inc.

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 InSphero

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Kerafast

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 MIMETAS BV

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 ORGANOVO HOLDINGS INC.

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 THERMO FISHER SCIENTIFIC INC.

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

North America Human Liver Models Market

Analysis By Type (Liver Organoids, Liver-on-a-chip, 2D Models, 3D Bioprinting, and Others), Application (Drug Discovery, Educational, and Others), and End User (Pharmaceutical and Biotechnology Companies, Research Institutes, and Others)